GENTIAN Stock Today

<div class='circular--portrait' style='background:#000000;color: #f2f2f2;font-size:4em;padding-top: 25px;;'>GD</div>
GENTIAN DIAGNOSTIC is trading at 52.00 as of the 29th of May 2020, which is 0.97 percent up since the beginning of the trading day. The stock's lowest day price was 49.40000153. GENTIAN DIAGNOSTIC has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 30 days. Equity ratings for GENTIAN DIAGNOSTIC are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 29th of February 2020 and ending today, the 29th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

  Performance0 100 


Gentian Diagnostics AS researches, develops, and produces biochemical reagents for use in medical diagnostics and research. The company was founded in 2001 and is headquartered in Moss, Norway. GENTIAN DIAGNOSTIC is traded on Oslo Stock Exchange in Norway. more on GENTIAN DIAGNOSTIC
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of GENTIAN DIAGNOSTIC available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
GENTIAN DIAGNOSTIC (GENT-ME) is traded on Oslo Stock Exchange in Norway . The company currently falls under 'Small-Cap' category with current market capitalization of 808.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GENTIAN DIAGNOSTIC's market, we take the total number of it shares issued and multiply it by the GENTIAN DIAGNOSTIC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. GENTIAN DIAGNOSTIC operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 15.4 M outstanding shares. The company has accumulated about 161.07 M in cash with (26.62 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.46.
Check GENTIAN DIAGNOSTIC Probability Of Bankruptcy

GENTIAN Stock Price Odds Analysis

Odds Down 52.0HorizonTargetOdds Up 52.0
69.01%30 days
Based on normal probability distribution, the odds of GENTIAN DIAGNOSTIC to move above current price in 30 days from now is about 30.88 (This GENTIAN DIAGNOSTIC probability density function shows the probability of GENTIAN DIAGNOSTIC Stock to fall within a particular range of prices over 30 days) .


GENTIAN Stock Against Markets

Did you try this?

Run Content Syndication Now


Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module
Please check Risk vs Return Analysis. Please also try Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page